AZP-3601 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
235	副甲状腺機能低下症	1

235. 副甲状腺機能低下症

臨床試験数 : 88 / 薬物数 : 107 - (DrugBank : 24) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 7

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05239221 (ClinicalTrials.gov)	September 7, 2020	7/1/2022	AZP-3601 SAD and MAD Study in Healthy Subjects and Subjects With Hypoparathyroidism	A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics ...	Chronic Hypoparathyroidism	Drug: AZP-3601;Drug: Placebo	Amolyt Pharma	NULL	Completed	18 Years	75 Years	All	132	Phase 1	Hungary;Netherlands

First Previous1Next Last